Impact Factor
3.59
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.85
6,503 total citations
h5-index
74
h5 depth signal
Cited share
34.7%
813 of 2,344
Total citations
6,503
Citation footprint
Metric signal
2.69
External metric anchor
Self-citation
16.7%
1,084 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Germany
1,979
United States
1,777
Italy
1,710
United Kingdom
1,623
Netherlands
1,290
Citing Fields of Research
Cardiology
10,822
Autonomic Function
1,009
Physiology
277
Anesthetic & Pain Medicine
179
Brain Neurological Disorders
120
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
20,981
Articles tracked across the journal lifetime
Indexed publication set
2,344
813 cited publications
Last 12 months
1,635
136.3 publications/month
Open access share
100.0%
1,635 OA publications in the last year
Leading citing country
Germany
1,979 citing publications
Leading citing field
Cardiology
10,822 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 1999-
v1n1, Jan. 1999-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Issuing & Sponsoring Bodies
Contributor
European Society of Cardiology
Broad Categories
Cardiology
Physiology
MeSH Descriptors
Arrhythmias, Cardiac
Cardiac Pacing, Artificial
Catheter Ablation
Electrophysiology
Heart
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/europace/euag282
Open DOI
Cellular consequences of non-ablative radiotherapy, a novel approach to ventricular tachycardias
Background and aims: Radiotherapy (RT) with a single application of ionizing radiation (STAR) has been suggested as a non-invasive alternative to radiofrequency in ablating ventricular tachycardia (VT). Emerging data reveal that STAR may...
02
DOI 10.1093/europace/euag295
Open DOI
Coexistance of Carotid Sinus Hypersensitivity and Orthostatic Hypotension in Patients with Unexplained Syncope
Background: Carotid sinus hypersensitivity (CSH) and orthostatic hypotension (OH) are established causes of syncope but are often considered separate entities. However, evidence suggests that CSH and OH may coexist and jointly contribute...
03
DOI 10.1093/europace/euag275
Open DOI
Pulsed Field Ablation as First-Line Therapy for the Treatment of Atrial Fibrillation: a FARADISE Sub-Analysis
04
05
DOI 10.1093/europace/euag272
Open DOI
Potassium-Increasing Regimens in Patients at High Risk of Ventricular Arrhythmias: A Prespecified Observational Analysis of the Randomized POTCAST Trial
Background and aims: The POTCAST trial (n=1,200) showed that targeting high-normal plasma potassium levels reduced ventricular arrhythmias in patients with Implantable Cardioverter-Defibrillators (ICDs). We compared changes in plasma pot...
06
DOI 10.1093/europace/euag286
Open DOI
Percutaneous Left Atrial Appendage Closure: The CHAMPION-like vs CLOSURE-like Patient Phenotype Framework
Aims: The near-simultaneous publication of CHAMPION-AF and CLOSURE-AF produced apparently discordant evidence regarding percutaneous left atrial appendage closure (LAAC) for stroke prevention in atrial fibrillation. We aimed to reconcile...
07
08
09
10
Bibliographical & Catalog Notes
Title from cover.
Imprint varies.
Supplements accompany some vols.
Also issued online.
v. 1, no. 1 (Jan. 1999)20001127 Notice published Printed on acid-free paper